Behavioral interventions in epilepsy

Sheryl R. Haut, Jonathan M. Gursky, Michael Privitera

Research output: Contribution to journalReview article

Abstract

Purpose of reviewBehavioral intervention describes multiple modalities of treatments which are of increasing interest in epilepsy. This review addresses recent behavioral clinical trials in epilepsy including cognitive behavioral therapy (CBT), mindfulness, progressive muscle relaxation (PMR), and self-management. Results and conclusions from updated Cochrane reviews and the recent International League Against Epilepsy Psychology task force are presented.Recent findingsTwo recent large randomized controlled trials (mindfulness and progressive muscle relaxation) reported improved seizure frequency with behavioral treatments. In both studies, participants in both the active and the attentional control arms showed significant seizure reduction, whereas quality of life and stress reduction were better noted in the active arms. Additional behavioral modalities have reported improved seizure control including yoga, bio/neurofeedback, and music therapy.Significant improvements in multiple quality of life, cognitive domains, and medication adherence have been reported from randomized and open label trials of cognitive behavioral therapy, and self-management programs. Multiple promising self-management programs have been recently reported, often utilizing the power of web-based apps, and digitally delivered group therapy. In 2018, the International League Against Epilepsy Psychology task force recommended that 'psychological interventions should be incorporated into comprehensive epilepsy care.'SummaryBehavioral treatments are successful and likely underutilized in the treatment of epilepsy. Given the challenge of conducting randomized clinical trials of behavioral therapy, much remains to be studied. However, for motivated and interested patients, appropriately chosen behavioral therapies appear to be important adjuncts to standard therapy. The timing is currently optimal to take best advantage of smartphone apps and web-based delivery systems, both for research and therapeutic purposes.

Original languageEnglish (US)
Pages (from-to)227-236
Number of pages10
JournalCurrent Opinion in Neurology
Volume32
Issue number2
DOIs
StatePublished - Apr 1 2019

Fingerprint

Epilepsy
Self Care
Autogenic Training
Mindfulness
Seizures
Cognitive Therapy
Advisory Committees
Psychology
Therapeutics
Randomized Controlled Trials
Neurofeedback
Quality of Life
Music Therapy
Yoga
Therapeutic Human Experimentation
Medication Adherence
Group Psychotherapy
Psychological Stress
Clinical Trials

Keywords

  • behavioral intervention
  • epilepsy
  • mind-body
  • self-management
  • stress reduction

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Behavioral interventions in epilepsy. / Haut, Sheryl R.; Gursky, Jonathan M.; Privitera, Michael.

In: Current Opinion in Neurology, Vol. 32, No. 2, 01.04.2019, p. 227-236.

Research output: Contribution to journalReview article

Haut, Sheryl R. ; Gursky, Jonathan M. ; Privitera, Michael. / Behavioral interventions in epilepsy. In: Current Opinion in Neurology. 2019 ; Vol. 32, No. 2. pp. 227-236.
@article{d25dd3638c634a27a5d2b25283fbad7a,
title = "Behavioral interventions in epilepsy",
abstract = "Purpose of reviewBehavioral intervention describes multiple modalities of treatments which are of increasing interest in epilepsy. This review addresses recent behavioral clinical trials in epilepsy including cognitive behavioral therapy (CBT), mindfulness, progressive muscle relaxation (PMR), and self-management. Results and conclusions from updated Cochrane reviews and the recent International League Against Epilepsy Psychology task force are presented.Recent findingsTwo recent large randomized controlled trials (mindfulness and progressive muscle relaxation) reported improved seizure frequency with behavioral treatments. In both studies, participants in both the active and the attentional control arms showed significant seizure reduction, whereas quality of life and stress reduction were better noted in the active arms. Additional behavioral modalities have reported improved seizure control including yoga, bio/neurofeedback, and music therapy.Significant improvements in multiple quality of life, cognitive domains, and medication adherence have been reported from randomized and open label trials of cognitive behavioral therapy, and self-management programs. Multiple promising self-management programs have been recently reported, often utilizing the power of web-based apps, and digitally delivered group therapy. In 2018, the International League Against Epilepsy Psychology task force recommended that 'psychological interventions should be incorporated into comprehensive epilepsy care.'SummaryBehavioral treatments are successful and likely underutilized in the treatment of epilepsy. Given the challenge of conducting randomized clinical trials of behavioral therapy, much remains to be studied. However, for motivated and interested patients, appropriately chosen behavioral therapies appear to be important adjuncts to standard therapy. The timing is currently optimal to take best advantage of smartphone apps and web-based delivery systems, both for research and therapeutic purposes.",
keywords = "behavioral intervention, epilepsy, mind-body, self-management, stress reduction",
author = "Haut, {Sheryl R.} and Gursky, {Jonathan M.} and Michael Privitera",
year = "2019",
month = "4",
day = "1",
doi = "10.1097/WCO.0000000000000661",
language = "English (US)",
volume = "32",
pages = "227--236",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Behavioral interventions in epilepsy

AU - Haut, Sheryl R.

AU - Gursky, Jonathan M.

AU - Privitera, Michael

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Purpose of reviewBehavioral intervention describes multiple modalities of treatments which are of increasing interest in epilepsy. This review addresses recent behavioral clinical trials in epilepsy including cognitive behavioral therapy (CBT), mindfulness, progressive muscle relaxation (PMR), and self-management. Results and conclusions from updated Cochrane reviews and the recent International League Against Epilepsy Psychology task force are presented.Recent findingsTwo recent large randomized controlled trials (mindfulness and progressive muscle relaxation) reported improved seizure frequency with behavioral treatments. In both studies, participants in both the active and the attentional control arms showed significant seizure reduction, whereas quality of life and stress reduction were better noted in the active arms. Additional behavioral modalities have reported improved seizure control including yoga, bio/neurofeedback, and music therapy.Significant improvements in multiple quality of life, cognitive domains, and medication adherence have been reported from randomized and open label trials of cognitive behavioral therapy, and self-management programs. Multiple promising self-management programs have been recently reported, often utilizing the power of web-based apps, and digitally delivered group therapy. In 2018, the International League Against Epilepsy Psychology task force recommended that 'psychological interventions should be incorporated into comprehensive epilepsy care.'SummaryBehavioral treatments are successful and likely underutilized in the treatment of epilepsy. Given the challenge of conducting randomized clinical trials of behavioral therapy, much remains to be studied. However, for motivated and interested patients, appropriately chosen behavioral therapies appear to be important adjuncts to standard therapy. The timing is currently optimal to take best advantage of smartphone apps and web-based delivery systems, both for research and therapeutic purposes.

AB - Purpose of reviewBehavioral intervention describes multiple modalities of treatments which are of increasing interest in epilepsy. This review addresses recent behavioral clinical trials in epilepsy including cognitive behavioral therapy (CBT), mindfulness, progressive muscle relaxation (PMR), and self-management. Results and conclusions from updated Cochrane reviews and the recent International League Against Epilepsy Psychology task force are presented.Recent findingsTwo recent large randomized controlled trials (mindfulness and progressive muscle relaxation) reported improved seizure frequency with behavioral treatments. In both studies, participants in both the active and the attentional control arms showed significant seizure reduction, whereas quality of life and stress reduction were better noted in the active arms. Additional behavioral modalities have reported improved seizure control including yoga, bio/neurofeedback, and music therapy.Significant improvements in multiple quality of life, cognitive domains, and medication adherence have been reported from randomized and open label trials of cognitive behavioral therapy, and self-management programs. Multiple promising self-management programs have been recently reported, often utilizing the power of web-based apps, and digitally delivered group therapy. In 2018, the International League Against Epilepsy Psychology task force recommended that 'psychological interventions should be incorporated into comprehensive epilepsy care.'SummaryBehavioral treatments are successful and likely underutilized in the treatment of epilepsy. Given the challenge of conducting randomized clinical trials of behavioral therapy, much remains to be studied. However, for motivated and interested patients, appropriately chosen behavioral therapies appear to be important adjuncts to standard therapy. The timing is currently optimal to take best advantage of smartphone apps and web-based delivery systems, both for research and therapeutic purposes.

KW - behavioral intervention

KW - epilepsy

KW - mind-body

KW - self-management

KW - stress reduction

UR - http://www.scopus.com/inward/record.url?scp=85071264228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071264228&partnerID=8YFLogxK

U2 - 10.1097/WCO.0000000000000661

DO - 10.1097/WCO.0000000000000661

M3 - Review article

C2 - 30694921

AN - SCOPUS:85071264228

VL - 32

SP - 227

EP - 236

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 2

ER -